<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00292279</url>
  </required_header>
  <id_info>
    <org_study_id>HL20020004</org_study_id>
    <nct_id>NCT00292279</nct_id>
  </id_info>
  <brief_title>The Impact of Omega-3 Fat Emulsion on Clinical Outcome of Post-Operative Cancer Patients</brief_title>
  <official_title>The Impact of Omega-3 Fat Emulsion on Clinical Outcome of Post-Operative Cancer Patients: A Randomized, Double Blind, Controlled, Multi-Center Clinical Trial.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Sino-Swed Pharmaceutical Corporation</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Sino-Swed Pharmaceutical Corporation</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to evaluate clinical safety and effect of Omega-3 fat oil
      emulsion on outcome in post-operative cancer patients.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      As an essential component of parenteral nutrition, fat emulsion has been used more than 30
      years. It provides energy and essential fatty acids. Commercial fatty emulsion products
      mostly come from soy bean. The omega 6 fatty acids make up with the major fatty acids of this
      fat emulsion, and lack of omega 3 fatty acids generally. The imbalance of these two types of
      fatty acids may impact with negative clinical outcomes.

      There are lots of omega 3 fatty acids makes up with fish oil emulsion, especially with
      eicosapentaenoic acid (EPA) and Docosahexaenoic acid (DHA).Few clinical studies found its
      clinical efficacy in recently years. A commercial product of omega 3 fat emulsion by
      Fresenius-Kabi was registered in Europe at 1998. There is no any clinical trial in Asia to
      elaborate the efficacy of omega 3 fat emulsion, as well the lack of large scale clinical
      trial in the world.

      Currently study is the first large scale, randomized, double blind and multi-center clinical
      trial to elaborate the impact of fish oil fat emulsion in Asia and Europe.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>June 2002</start_date>
  <completion_date type="Actual">February 2004</completion_date>
  <primary_completion_date type="Actual">November 2003</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Infectious complication</measure>
    <time_frame>POD+1 to POD+14</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Systemic inflammatory response syndrome (SIRS)</measure>
    <time_frame>POD+1 to POD +8</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Post-operative hospitalization days</measure>
    <time_frame>POD+1 to discharge</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Post operative nutritional cost &amp; total treatment cost</measure>
    <time_frame>POD+1 to discharge</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">206</enrollment>
  <condition>Carcinoma Surgery</condition>
  <condition>Parenteral Nutrition</condition>
  <condition>Post-Operative Hospital Stay</condition>
  <arm_group>
    <arm_group_label>A</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>B</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Omega-3 fish oil emulsion (Omegaven )</intervention_name>
    <description>Patients of the treatment group received 0.2 g fish oil (10% Omegaven, Fresenius Kabi, Bad Homburg, Germany) and 1.0 g soy bean oil per kg BW per day</description>
    <arm_group_label>A</arm_group_label>
    <other_name>Omegaven</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>long-chain triglyceride</intervention_name>
    <description>the control group received 1.2 g soy bean oil (Intralipid, Sino-Swed,Wuxi,China)</description>
    <arm_group_label>B</arm_group_label>
    <other_name>Intralipid</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Post-operative male and female cancer patients

          -  Require post operative parenteral nutrition support at least 7 days based on
             nutritional risk screening(BMI 20-25)

          -  Sign an informed consent

        Exclusion Criteria:

          -  Diabetes Mellitus

          -  Abnormal fatty metabolism (TG&gt;200mg/dl or cholesterol&gt;240mg/dl )

          -  Renal dysfunction (Cr&gt;1.6mg/dl or BUN&gt;30mg/dl)

          -  Liver dysfunction (ALT&gt;60U/L or TBIL&gt;1.2mg/dl)

          -  Lienectomy

          -  Temperature&gt;37.5Â°C

          -  Undergoing hormone therapy

          -  Pregnancy
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Zhu-ming Jiang, FACS</last_name>
    <role>Study Director</role>
    <affiliation>Peking Union Medical College Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>People's Hospital, Beijing University</name>
      <address>
        <city>Beijing</city>
        <zip>100044</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Beijing Friendship Hospital</name>
      <address>
        <city>Beijing</city>
        <zip>100050</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Beijing Hospital</name>
      <address>
        <city>Beijing</city>
        <zip>100730</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Peking Union Medical College Hospital</name>
      <address>
        <city>Beijing</city>
        <zip>100730</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>General Hospital Of PLA</name>
      <address>
        <city>Beijing</city>
        <zip>100853</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <results_reference>
    <citation>(Abstract) ZM Jiang, XR Wang, JM Wei, Y. Wang, Y. Li, S Wang, DW Wilmore. The impact of i.v. fish oil emulsion on clinical outcome &amp; immune functions of post-operative cancer patients: a randomized, double blind, controlled, multi-center clinical trial for 203 cases Clinical Nutrition(Abstract for ESPEN 2005)(Absract No. 181)</citation>
  </results_reference>
  <verification_date>May 2008</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 13, 2006</study_first_submitted>
  <study_first_submitted_qc>February 13, 2006</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 15, 2006</study_first_posted>
  <last_update_submitted>May 12, 2008</last_update_submitted>
  <last_update_submitted_qc>May 12, 2008</last_update_submitted_qc>
  <last_update_posted type="Estimate">May 14, 2008</last_update_posted>
  <responsible_party>
    <name_title>TF Ye</name_title>
    <organization>Ethic Committee of Peking Union Medical College Hospital</organization>
  </responsible_party>
  <keyword>Impact of Omega 3 fatty acid on outcome</keyword>
  <keyword>Omega-3 fatty acid</keyword>
  <keyword>Carcinoma surgery</keyword>
  <keyword>Digestive System</keyword>
  <keyword>Parenteral Nutrition</keyword>
  <keyword>Fat Emulsions, Intravenous</keyword>
  <keyword>Clinical outcome</keyword>
  <keyword>SIRS</keyword>
  <keyword>Infectious complication</keyword>
  <keyword>Postoperative hospital stay</keyword>
  <keyword>Cost of postoperative period</keyword>
  <keyword>Post-operative nutritional cost &amp; total treatment cost</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Soybean oil, phospholipid emulsion</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

